Todd P. Branning - 10 Jan 2022 Form 4 Insider Report for NeuBase Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Dietrich Stephan, as attorney-in-fact for Todd Branning
Issuer symbol
N/A
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
4
Filing time
10 Jan 2022, 18:19:44 UTC
Next filing
18 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Employee stock option (right to buy) Award $0 +300,000 $0.000000 300,000 10 Jan 2022 Common stock 300,000 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.